These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7577798)
1. Isolation of a human allo-peptide presented by HLA-B51 molecules. Tomiyama H; Takamiya Y; Hill AB; Cerundolo V; Kelly A; Egawa K; Trowsdale J; Takiguchi M Int Immunol; 1995 Jun; 7(6):905-9. PubMed ID: 7577798 [TBL] [Abstract][Full Text] [Related]
2. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules. Tomiyama H; Yamada N; Komatsu H; Hirayama K; Takiguchi M Eur J Immunol; 2000 Sep; 30(9):2521-30. PubMed ID: 11009085 [TBL] [Abstract][Full Text] [Related]
3. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757 [TBL] [Abstract][Full Text] [Related]
4. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. Poindexter NJ; Naziruddin B; McCourt DW; Mohanakumar T J Immunol; 1995 Apr; 154(8):3880-7. PubMed ID: 7535816 [TBL] [Abstract][Full Text] [Related]
5. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521 [TBL] [Abstract][Full Text] [Related]
6. The role of the conserved residue in pocket A and the polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells. Takiguchi M; Kawaguchi G; Sekimata M; Hiraiwa M; Kariyone A; Takamiya Y Int Immunol; 1994 Sep; 6(9):1345-52. PubMed ID: 7819142 [TBL] [Abstract][Full Text] [Related]
7. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. Tomiyama H; Sakaguchi T; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M Hum Immunol; 1999 Mar; 60(3):177-86. PubMed ID: 10321954 [TBL] [Abstract][Full Text] [Related]
8. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095 [TBL] [Abstract][Full Text] [Related]
9. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. Smith KD; Huczko E; Engelhard VH; Li YY; Lutz CT Transplantation; 1997 Jul; 64(2):351-9. PubMed ID: 9256200 [TBL] [Abstract][Full Text] [Related]
10. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules. Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996 [TBL] [Abstract][Full Text] [Related]
11. Endogenous expression and HLA stabilization assay of Plasmodium falciparum CTL epitope minigene in human HLA-A2. 1 and HLA-B51 cells. Tang Y; Wang H Chin Med Sci J; 2001 Mar; 16(1):29-34. PubMed ID: 12899345 [TBL] [Abstract][Full Text] [Related]
12. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. Crumpacker DB; Alexander J; Cresswell P; Engelhard VH J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446 [TBL] [Abstract][Full Text] [Related]
13. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51. Thimme R; Chang KM; Pemberton J; Sette A; Chisari FV J Virol; 2001 Apr; 75(8):3984-7. PubMed ID: 11264388 [TBL] [Abstract][Full Text] [Related]
14. Effect of the substitutions in the alpha helix and the beta sheet of HLA class I molecule on allorecognition of T cells specific for HLA-B51 and HLA-Bw53. Hiraiwa M; Nishimura I; Kato N; Nagao T; Kano K; Takiguchi M Hum Immunol; 1992 Feb; 33(2):82-8. PubMed ID: 1373416 [TBL] [Abstract][Full Text] [Related]
15. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid. Herman J; Jongeneel V; Kuznetsov D; Coulie PG Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611 [TBL] [Abstract][Full Text] [Related]
16. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Kikuchi A; Sakaguchi T; Miwa K; Takamiya Y; Rammensee HG; Kaneko Y; Takiguchi M Immunogenetics; 1996; 43(5):268-76. PubMed ID: 9110930 [TBL] [Abstract][Full Text] [Related]
17. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity. Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931 [TBL] [Abstract][Full Text] [Related]
18. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells. Nakayama S; Kawaguchi G; Karaki S; Nagao T; Uchida H; Kashiwase K; Akaza T; Nasuno T; Takiguchi M Hum Immunol; 1994 Mar; 39(3):211-9. PubMed ID: 8026989 [TBL] [Abstract][Full Text] [Related]
19. Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones. Matsumoto K; Yamamoto J; Hiraiwa M; Kano K; Takiguchi M Transplantation; 1990 Jun; 49(6):1164-7. PubMed ID: 2360256 [TBL] [Abstract][Full Text] [Related]
20. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures. Shi Y; Smith KD; Lutz CT J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]